Table 1.
Demographic and Anthropometric Characteristics of the Sample
|
Characteristic | |
| Age, years |
11.8 (±2.9) |
| Males, n (%) |
98 (89%) |
| Tanner Stage: I, II, III, IV, V (%) |
36/14/18/22/10 |
| Race, n (%) |
|
| White |
87 (79) |
| African American |
17 (15) |
| Hispanic |
5 (5) |
| Other |
1 (1) |
|
Anthropometric/Metabolic Data | |
| Birth Weight z Scorea (n=98) |
-0.29 (±0.99) |
| Baseline Weight z Scoreb |
0.17 (±1.02) |
| Baseline BMI z Scoreb (n=107) |
0.18 (±1.05) |
| Enrollment Weight, Kg |
49.1 (±18.3) |
| Enrollment Weight z Score |
0.72 (±1.03) |
| Enrollment Weight, Kg/m2 |
20.9 (±4.6) |
| Enrollment BMI z Score | 0.73 (±1.02) |
a This was adjusted for sex and gestational age [31].
b Baseline sex- and age-adjusted weight or body mass index (BMI) z scores included those available upon or within the month prior to starting risperidone.